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ABSTRACT: Previously, we showed that macroporous tita-
nium implants, colonized in vivo together with an epithelial
graft, are viable options for tracheal replacement in sheep.
To decrease the number of operating steps, biomaterial-
based replacements for epithelial graft and intramuscular
implantation were developed in the present study. Hybrid
microporous PLLA/titanium tracheal implants were
designed to decrease initial stenosis and provide a surface
for epithelialization. They have been implanted in New
Zealand white rabbits as tracheal substitutes and compared
to intramuscular implantation samples. Moreover, a base-
ment membrane like coating of the implant surface was also
designed by Layer-by-Layer (LbL) method with collagen and
alginate. The results showed that the commencement of
stenosis can be prevented by the microporous PLLA. For
determination of the optimum time point of epithelializa-
tion after implantation, HPLC analysis of blood samples,
C-reactive protein (CRP), and Chromogranin A (CGA)
analyses and histology were carried out. Following 3 weeks
the implant would be ready for epithelialization with respect
to the amount of tissue integration. Calcein-AM labeled
epithelial cell seeding showed that after 3 weeks implant
surfaces were suitable for their attachment. CRP readings
were steady after an initial rise in the ﬁrst week. Cross-linked
collagen/alginate structures show nanoﬁbrillarity and they
form uniform ﬁlms over the implant surfaces without
damaging the microporosity of the PLLA body. Human
respiratory epithelial cells proliferated andmigrated on these
surfaces which provided a better alternative to PLLA ﬁlm
surface. In conclusion, collagen/alginate LbL coated hybrid
PLLA/titanium implants are viable options for tracheal
replacement, together with in situ epithelialization.
Biotechnol. Bioeng. 2012;109: 2134–2146.
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Introduction
Respiratory system diseases are one of the most common
causes of death, especially in high income countries. For
example, tracheal restenosis might become a problem that
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can necessitate surgery. Moreover, tracheal damages due to
cancer and congenital diseases are quite common and even
though end-to-end anastomosis can solve the problem
for short lengths (<5 cm) (Roomans, 2010), implants are
necessary if the problem is recurrent or the damaged area is
above the limits of end-to-end anastomosis. In recent years
several commendable efforts in the area of trachea tissue
engineering have given very promising results, especially the
systems byMacchiarini et al. (2008) and Delaere et al. (2010)
have shown possible routes to improve the life quality of the
patients. However these systems are dependent on allograft
availability and long production periods with high level
of expertise, which has also been stated by the authors
themselves in their recent reviews (Bader and Macchiarini,
2010). It was also discussed widely whether a more in situ
approach might be more beneﬁcial, as trachea is surgically
accessible. In such a scheme, some elements of the
regeneration were either induced within the body or added
after the initial implantation. It has been suggested that the
in situ epithelialization might be a more attractive option as
the survival of the epithelial cells seeded initially is low
(Nakamura et al., 2009; Omori et al., 2008). Thus more
widespread and easily transferable solutions are still
necessary. Current systems available are either dependent
on cartilage production for the airway stability and
prevention of collapse or in vivo migration of epithelial
cells or epithelial graft for remodeling. Porous titanium
technology is an interesting venue to provide biointegrable
implants without any concerns on mechanical stability. It is
composed of titanium microbeads put together with an
electrical arc, which provides a macroporous, low density
and yet stable implant system, with an easier production
procedure compared to most of porous metal implants
(Ryan et al., 2006). We have previously utilized the titanium
tracheal implants in mice and sheep with success (Schultz
et al., 2002, 2004). Other groups also had success with
titanium implants in respiratory area (Janssen et al., 2009,
2010). Trachea is an advantageous area for reconstruction as
it is a thin tissue with relatively low oxygen requirements
(Kalathur et al., 2010). The main problems encountered
in the previous studies were the absence of epithelium for
large defects for which there is no possibility of epithelium
grafting (skin, mouth, etc.) and an extensive risk of
restenosis. Grafting can be a viable route but its availability
is a difﬁculty and more importantly the differentiated
state of the graft might cause problems in the target area
(such as hair growth or excessive keratinization), so a
surface that would facilitate epithelial growth is a preferred
option. Utilization of the advantageous properties of two
material types either as hybrids or composites is generally
necessary in the ﬁeld of biomaterials (Nicole et al.,
2010). Thus utilizing a biodegradable structure, such as a
polymer foam, within a biocompatible metallic template is
feasible to control cellular movement also in vivo. A
prerequisite for colonization of a porous tracheal implant
is also to prevent restenosis of the lumen. For example,
macropores with a microporous body might slow down
cellular movement and prevent restenosis as we have
shown previously (Vrana et al., 2011). However, advantages
of a single operation procedure can be overshadowed by
the extent of immune response. Also the level of epithelial
migration might not be enough for full coverage of the
implant surface. For this end, a surface coating which would
provide a better medium for epithelial movement would be
useful. Layer-by-Layer (LbL) ﬁlm production methodology
can be used for this aim with natural molecules such
as collagen to make surface properties more basement
membrane-like. LbL ﬁlms are extremely simple to build up
and they are also very versatile, that is, thickness, surface
charge, mechanical parameters can be tuned easily by
changing the number of deposited layers or the buildup
conditions.
In order to decide for the right conditions for in situ
epithelialization, monitoring of implant integration is
necessary. Also since in trachea, implant failures can be
fatal, their strict monitoring is crucial (Grillo, 2002). For
this end, rabbits are appropriate models as the shape and
relative size of their trachea is a good mimic of that of
humans when normalized with respect to their size (ten
Hallers et al., 2004). Moreover, rabbits are very susceptible
to pulmonary infections, as such infections have been
cited as one of the most common causes of death in rabbits
(Rougier et al., 2006). This is relevant in the sense that,
after implantation due to the unsterile environment of the
tracheal passage, the implants might be prone to develop-
ment of infection. This should be taken into account as
the products are developed for clinical trials, for example,
abrupt loss of animals has regularly been reported during
similar interventions (Tatekawa et al., 2010). Due to these
problems, detection of infections and removal of pathogens
are extremely important. Determination of pathogen related
peptides and monitoring of inﬂammation/immune system
response related molecules by HPLC can thus provide
crucial information on post-operational care of the
implant. It has been utilized in a wide range of in vivo
detection problems such as transplant rejection or cytotoxic
material presence (Horuk et al., 2001; Tseng et al., 2005).
C-reactive protein (CRP) is a common marker of
inﬂammation and infection which has found clinical
applications. Recently Chromogranin A (CGA, a severity
marker) has also been shown to be a potent agent for
infection and inﬂammatory response detection. In this
study, a hybrid implant for tracheal implantation was
monitored in vivo for its effectiveness in cell movement
control and for determination of the right time period
for secondary seeding of autologous epithelial cells with
respect to animal health and tissue integration. The
monitoring of animal condition was done by regular
blood tests based on CRP levels and characterization of
blood samples by HPLC and subsequent peptide sequenc-
ing. Also a surface modiﬁcation of the implant was done
with LbL methodology to provide a more basement
membrane like structure for migration of respiratory
epithelium cells.




Rabbit CRP ELISA kit was obtained from Helica Biosystems
(Fullerton, CA) and Triple Express from Gibco/Life
Technologies (Saint Aubin, France). Collagen type I (source:
Bovine) was obtained from Symatese (Lyon, France) and
alginate from Novamatrix (Pronova UPLVG medical
grade, FMC Biopolymers AS Novamatrix, Sandvika,
Norway). The rest of the products including, poly(L-lactic
acid) (PLLA), chloroform, dioxane, and TOX-8 were
purchased from Sigma–Aldrich (Saint Quentin Fallavier,
France).
Animal Model
Adult White New Zealand rabbits (n¼ 10) between 14 and
16 weeks of age and weighing an average of 3 kg were used
for this study. Each animal received care in compliance with
the Guide for the Care and Use of Laboratory Animals
(National Research Council, 2010) and were housed in our
institution at the Faculty of Medicine of Strasbourg
(France). They were fed with a standard laboratory diet
and tap water ad libitum.
Methods
Implant Production
Porous titanium implants with an inner diameter of
7mm and an outer diameter of 10mm were produced
by previously deﬁned electric-arc discharge method by
using 400–500mm diameter beads. The ﬁnal length of the
implants was 2 cm. A circular insert of 6mm was cut out
of the implant body with a laser beam (IREPA Laser,
Illkirch, France) for posthumous investigations. The body
of the implant was ﬁlled with a porous PLLA structure as
described previously (Vrana et al., 2011). Brieﬂy a 6%
PLLA solution in dioxane/water binary mixture (v:v 87/
13%) was heated to 608C and then poured into a Teﬂon
mold that contains the titanium implant. Then the system
was left for gelation at room temperature for 30min and
then frozen at 708C overnight. The system was rendered
porous by freeze extraction with an extraction step in
cold 80% ethanol (Goh and Ooi, 2008). The outer element
of the mold has been previously removed and only the
mandrel was left. This creates an open pore gradient
from extraluminal side to intraluminal side. Finally a
layer of 1% PLLA ﬁlm was laid into the lumen and then
precipitated with the application of EtOH (Fig. 1). The ﬁnal
structure was washed several times with PBS and
then sterilized in an antibiotic/antimitotic cocktail as
suggested previously (Shearer et al., 2006) followed by
UV sterilization.
In Vivo Experiments
Anesthesia. All surgeries were performed under general
anesthesia. Anesthesia was induced by intramuscular
administration of ketamine (30mg/kg, Ketamine1 500;
Virbac, Carros, France) in combination with midazolam
(0.2mg/kg, Mydazolam1; Mylan, Saint Priest, France)
and xylazine (3mg/kg, Rompun1; Bayer AG; Leverkusen,
Germany) and assisted ventilation (O2:1 L/min).
Postoperative analgesia was maintained by fentanyl patch
(3mg, Fentanyl-Mepha1; Mepha Pharma, Aesch, Switzerland)
for 6 days.
Surgical technique. All operations were performed under
sterile conditions. With the animal in the supine position
after a vertical midline cervicotomy, the infrahyoid muscles
were separated from the tracheal axis. After dissecting to the
level of the thyroid, a tracheal segment of three to four rings
(15mm) was resected. Each tracheal extremity was then
inserted into the prosthesis, which replaced the defect.
A silicone tube was placed in the titanium prosthesis and
sutured to the prosthesis with one proximal stitch (vicryl
4.0). The porous titanium prosthesis and the tracheal
extremities were joined by four proximal and distal sutures
(vicryl 4.0). Before closing the skin and the subcutaneous
layers without drainage, a myoplasty was performed to cover
the prosthesis and limit possible peritracheal leakage.
A tracheal segment, silicone tubes (stents) were used
for the endoluminal calibration of the porous titanium
prostheses for the in vivo experiments. They were 40mm
long with an internal diameter of 5mm. They protruded
from each end of the prosthesis by 10mm, thus providing
protection of the tracheo-prosthetic anastomoses.
Implant Follow-Up
A daily clinical follow-up was performed. Data regarding
the general well-being of the animals and their weight were
recorded throughout the duration of the experiment.
Implantation period was 6 weeks and regular CRP
readings were taken weekly by an ELISA kit to determine
the level of inﬂammation as per the instructions of the
manufacturer. Blood was obtained from the auricular
veins and centrifuged at 5,000 rpm at 48C for 20min, the
supernatant was obtained and tested for CRP levels. The rest
of the plasma was utilized for further characterization.
Plasma Characterization
Puriﬁcation of proteic material by reverse phase HPLC.
Soluble biological material was obtained by acidic extraction
with 0.1% of triﬂuoroacetic acid of rabbit plasma (1/1, v/v).
The soluble extract was puriﬁed using a Dionex HPLC
system (Ultimate 3000; Sunnyvale, CA) on a nucleosil
reverse-phase 300-5C18-column (4mm 250mm; particle
size 5mm; porosity, 300 A˚, Macherey Nagel, Hoerdt,
France). Absorbance was monitored at 214 and 280 nm,
and the solvent system consisted of 0.1% ( v/v)
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triﬂuoroacetic acid (TFA) in water (solvent A) and 0.09%
(v/v) TFA in 70% (v/v) acetonitrile–water (solvent B).
Elutions were performed at a ﬂow rate of 700mL/min using
gradients indicated on chromatograms. Each peak fraction
was collected and concentrated by evaporation, but not to
dryness with the speed-vac.
Western blotting. Samples were loaded on 15% SDS–PAGE
and then transferred to PVDFmembrane (HyBondTM-P, GE
Healthcare). During migration a voltage of 50 V was applied
for the ﬁrst 10min and then 120V till end and during
transfer 75 V was used for 90–100min. For immunodetec-
tion Millipore Snap i.d. protein detection system was
used using 0.5% of bovine serum albumin as blocking
agent. Antibodies used were monoclonal anti-CGA (anti-
CGA47–68). Secondary antibodies used were goat anti-mouse
immunolabeled bands were visualized by using the imager
system ChemiDoc XRS (Bio-Rad, Marne-la-Coquette)
after addition of ECL reagent (Amersham Bio-Science,
Buckinghamshire, UK). To compare with our previous
technique (intramuscular implantation prior to tracheal
replacement) (Dupret-Bories et al., 2011), the CGA tests
were also done for the samples obtained from animals who
received a tracheal titanium implant with or without
epithelial cells after 3 weeks of intramuscular implantation.
Brieﬂy, the steps were (i) implantation of titanium endo-
prosthetic tube under the infrahyoid muscles (day 0);
(ii) implantation of the prosthesis to replace a resected
tracheal segment (day 21). After placing the animal in
the supine position, a cervicotomy was performed with a
midline vertical incision, allowing access to the infrahyoid
muscles, which was separated from the tracheal axis. The
prosthesis was placed between the infrahyoid muscles and
the trachea. Then a silicon tube was inserted into the porous
titanium prosthesis. The skin and subcutaneous layers were
then closed with separated stitches of Vicryl 2.0. After
21 days, the cervical cutaneous incision was reopened.
Figure 1. Scheme of the proposed implant, as macroporous structure of titanium implants does not hinder cell movement (a). A hierarchically porous PLLA body with a thin
ﬁlm layer facing the lumen has been introduced (b). c,d: Macroscopic view of titanium only and titanium PLLA implants. SEM images of (e) extraluminal and (f) intraluminal surfaces
of the implant (from microporous surface to a smooth surface). g: The perspective view of the ﬁnal implant model, where the titanium beads are engulfed by the hierarchically
porous PLLA body.[Color ﬁgure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/bit]
Vrana et al.: Modiﬁcation of Macroporous Titanium Tracheal Implants 2137
Biotechnology and Bioengineering
The initial silicon tube was removed from the titanium
prosthesis and replaced with a new silicone tube (placed
inside the porous titanium prosthesis) that was sutured to
the prosthesis with one proximal stitch (Vicryl 4.0). The
prosthesis was laterally transposed (with its endoluminal
surface covered with epithelium) to replace a 2 cm tracheal
segment which was resected during the same operation. The
proximal and distal tracheal extremities were inserted into
the titanium prosthesis and the junctions of the prosthesis
and the tracheal extremities were joined with 6 sutures of
vicryl 4.0. Before closing the skin and subcutaneous tissue, a
myoplasty was performed to improve coverage and limit
future leakage.
Automatic Edman sequencing of peptides derived from the
plasma. The N-terminal sequence of puriﬁed peptides
was determined by automatic Edman degradation on a
Procise microsequencer (Applied Biosystems, Courtaboeuf,
France). Samples puriﬁed by HPLC were loaded to
polybrene-treated glass-ﬁber ﬁlters. Phenylthiohydantoin-
amino acids (Pth-Xaa) were identiﬁed by chromatography
on a C18 column (PTH C-18, 2.1mm 200mm) (Gasnier
et al., 2004). For the identiﬁcation of the sequence SWISS-
Prot database was used by Blast software.
Histological Analysis
After an observation period ranging from 1 to 6 weeks, the
rabbits were euthanized with an intravenous overdose of
sodium pentobarbital (120mg/kg, CEVA Sante´ Animale,
Libourne, France) after intramuscular administration of
anesthesia (the same protocol previously described). A
block resection, including surrounding tissues as well as
the prosthesis, was performed. After explantation, the
inserts where removed and observed with scanning
electron microscopy (SEM) and confocal microscopy to
check the structure and the presence of PLLA respectively.
The implants were explanted at 2nd, 3rd, and 6th weeks
of implantation and the histological cuts and hemotoxylin
and eosin staining was done as reported previously (Schultz
et al., 2007). Histological analyses were performed at the
IMM (Institut Mutualiste Monsouris, Paris, France), where
the blinded analyses were performed by two pathologists not
involved in the project.
Collagen/Alginate LbL Production
Collagen type I and Alginate were dissolved at 0.5mg/mL in
0.15M NaCl buffer at pH 4. LbL ﬁlms were constructed on
PLLA/titanium implants with an automated dipping robot
where for each layer a 1:1 ratio of each polyelectrolyte was
applied for equal time periods. The duration of dipping was
8min for each polyelectrolyte with 5min washing steps in
between until 24 bilayers were reached. During the ﬁlm
construction, all the rinsing steps were performed with a
10mM citrate buffer containing 0.15M NaCl at pH 4.
Cross-linking of the ﬁlm layers on the implants was achieved
by chemical cross-linking via genipin. Genipin solution
(20mg/mL) was prepared by dissolving 20mg of the genipin
powder in DMSO/buffer (0.15MNaCl, pH 4) mixture (1:5).
The cross-linking agent solution was let in contact with
the coated PEM ﬁlm for 12 h, followed by several rinsing
steps. Formed ﬁlm layers were characterized by atomic
force microscopy (AFM) and SEM imaging.
Epithelial Cell Culture
The use of human tissues was authorized by the French
committee ‘‘Comite´ de Protection des Personnes’’ (CPP-Est
III, Nancy), statement number DC-2008-374. Nasal polyps
were taken with a written consent from the patients. Human
respiratory Epithelial cells were obtained from freshly
removed nasal polyps as described before (LeSimple et al.,
2007). Cells were seeded on collagen/alginate covered
hybrid PLLA/titanium implants as 5 104 cells/implant.
Cell proliferation was observed by a Resazurin-based
proliferation assay (n 6) and morphology of the cells
by ﬂuorescence microscopy (DAPI and ZO-1 immuno-
staining). Migration of the epithelial cells was quantiﬁed
by time lapse microscopy and compared to the positive
controls, collagen type IV and collagen type I coatings
(n 40).
Results
Implant Patency and Fibroblast Movement
The developed method produces a PLLA body within
the titanium template with a porosity of 40–60mm
at the extraluminal part to 5–10mm intraluminally. This
structure enables the entry of ﬁbroblasts and macrophages
but prevents their migration into the lumen area (Vrana
et al., 2011). The addition of the PLLA ﬁlm layer in the
intraluminal side was necessary to provide a surface for
epithelial cells to migrate from anastomosis sites. The ﬁlm
layer was a surface visible on the structure of the implant
(Fig. 1e). It has been previously shown that such systems
can affect the movement of cells in vitro (Matschegewski
et al., 2010).
All animals survived the surgical procedure. Implan-
tations went uneventful except removal of the sutures by two
rabbits 1 day after implantation. This rabbits were treated
with local antiseptics, but one of them was lost at week 4 due
to deep infection of the wound site. Another rabbit was
lost due to peri-implantitis. Upon explantation, all implants
were in contact with the native trachea wall, both in
proximal and distal ends. In histological sections, ﬁbroblasts
are observed together with occasional multinucleated cells
(Fig. 2). For ﬁbroblast migration a similar behavior to that of
in vitro conditions was seen in vivo, as there was a distinct
decrease in the ﬁbroblast movement in hybrid implants
compared to titanium only implants. In the case of hybrid
implants the ﬁbroblast were able to get into the polymer
body (cells were visible inside the foam after 2 weeks and
their depth of movement gradually increased), but they
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have not been able to reach the lumen side over a 6-week
period (Fig. 2a–c). During this period, ﬁbrovascular tissue
surrounded the implant with noticeable growth into
the polymer body, which has reached the middle part of
the implant after 6 weeks (Fig. 2c, inset). The only titanium
implants were colonized totally in 1 month period (Fig. 2d)
and there was no way of keeping cell growth away from
the lumen, thus ﬁbroblasts in the lumen area were clearly
visible, which suggested that longer periods would result in
restenosis. Effectively the hybrid system is a temporary
obstacle for the ﬁbrovascular tissue inﬁltration which
prevents the overcome of epithelial growth by ﬁbroblasts.
In other words, presence of polymer body kept the growth of
the ﬁbrous tissue back to give epithelium enough time to
grow.
CRP, CGA, and Blood Protein Levels
The change in rabbit health was monitored by CRP levels.
CRP is an acute phase protein and it has been established as a
good method to monitor inﬂammation. In this scheme,
inﬂammation might come from two sources: inﬂammation
due to reaction to the implant and inﬂammation due to
infection. When there is no infection symptoms CRP
readings dropped after an initial hike in the ﬁrst week and
stayed only slightly over the baseline of healthy animals over
6 weeks, but they were still below the acceptable limit for
CRP in rabbits (5 ng/mL) (Fig. 3a). CRP readings for normal
animals were around the levels of previously published
reports (below 5 ng/mL) (Alvarez et al., 2008). However,
when there was an infection, before the symptoms became
Figure 2. Histology after explantation. For PLLA/titanium implants cellular movement was controlled by PLLA presence; ﬁbroblasts were restricted to the surrounding area in
week 2 (a) then their movement into the implants was more apparent by week 3 (b) and week 6 (c). By week 6 whole implant was covered with the ﬁbrovascular tissue with the
tissue ingrowth into the implant, without the presence of ﬁbroblasts in the lumen. On the other hand, only titanium implant was inﬁltrated with ﬁbrotic tissue after 1 month (d) but the
lumen has been started to be colonized which will end up in restenosis. e: The mode of ingrowth was from the extraluminal side. The tissue within the implants had distinct blood
vessels. Epithelium movement was restricted to the areas close to the anastomosis sides and even though the amount was higher in PLLA/titanium implants, the middle area of the
implants lacked epithelial cells. Thus, after initial integration an in situ seeding of autologous epithelial cells might be necessary. [Color ﬁgure can be seen in the online version of
this article, available at http://wileyonlinelibrary.com/bit]
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Figure 3.
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apparent, CRP levels elevated steeply (Fig. 3b). For example,
one of the animals had elevated CRP levels (above 20 ng/mL)
and then started to show infection symptoms. This animal’s
trachea was cleared with a small intervention and animal was
healthy afterwards and survived up until the pre-determined
sacriﬁce date. This showed that CRP levels are a good early
warning method (Lo¨bler et al., 2002). To further check
this trend the proteome analysis were done in the serum
samples over a timeline of 6 weeks, 1 animal who died of
a wound site infection was used as negative control and
a healthy animal as positive control. The HPLC proﬁle
showed distinct peaks corresponding to alpha and beta
hemoglobin ½ as determined by Edman sequencing
(Fig. 3c,d). Animals with tracheal implants show an increase
in both hemoglobin alpha and beta ½ amount after 1 week
of implantation compared to healthy animals, followed by a
progressive decrease in 2, 4, and 6 weeks. Similar to the CRP
readings, in case of an infection there was a very strong
increase in alpha and beta hemoglobin ½ readings.
When the levels of CGA was checked at time points 3, 4,
and 6 weeks, the level of unprocessed CGA (72 kDa) stayed
stable, but an increase in the processed CGA (20 kDa) was
observed (Fig. 4a). This processed CGA fragment (20 kDa)
is known to be involved in improving cell attachment
(Colombo et al., 2002). As CGA has been previously shown
to be an even better indicator of stress (Shooshtarizadeh
et al., 2010; Zhang et al., 2009), this check would be robust
warnings for the set of infection and subsequent treatment.
Moreover, they provide a means to compare different
protocols in their inﬂuence in body response. When
compared to our previous two-step method (intramuscular
implantation and after 21 days, tracheal implantation), the
PLLA/titanium hybrid system had less complete CGA.
Processed CGA levels of two steps method after 1 week of
tracheal implantation were at the level of 6 weeks for PLLA/
titanium hybrid system (Fig. 4b). This methodology would
open up a venue for checking the implantation behavior in
a broader sense and speciﬁc to each animal, as tracheal
replacement is a debilitating process and such methods for
patient-based monitoring are necessary. When collaborated
with the histology and CRP results, these results suggested
that for initial ﬁbrovascular population of the implants,
3 weeks period was necessary, during this period the initial
immune response to implantation decreases but also the
animals gradually become more prone to respiratory
infections, mainly due to the lack of epithelium. Thus,
after in vivo colonization of implant by the surrounding
tissue for 3 weeks, the structure will be ready for local
antibiotic treatment and subsequent in situ epithelialization.
Epithelialization
The luminal surface of the implant is designed as a smooth
ﬁlm layer to facilitate epithelial cell attachment and
migration. SEM imaging of the implant inserts after
explantation showed that the ﬁlm layer was largely intact
after 4 weeks of in vivo incubation (Fig. 5). This layer has
Figure 4. Western blots for determination of complete and/or digested CGA during the course of implantation. a: Animals which were implanted with PLLA/titanium implants
over 6 weeks, complete CGA levels were similar, but the digested CGA (an N-terminal fragment) increased over time. b: comparison of PLLA/titanium hybrid implant procedure (3, 4,
and 6 weeks denoted 3w, 4w, and 6w respectively) with two steps implantation protocol developed previously (Dupret-Bories et al., 2011) (intramuscular implantation, followed by
tracheal implantation denoted 4 and 4c, where c corresponds to addition of epithelial cells. PSG stands for Positive control. The CGA levels were signiﬁcantly higher in the cases of
two steps implantation.
Figure 3. Animal health checks. a: CRP readings on healthy and implanted animals over 6 weeks, CRP levels decrease over implantation period after an initial increase.
b: when there is infection an increase in CRP signal was observed. c: HPLC separation of plasma samples obtained from the animals over the course of implantation, where the
proﬁle of an healthy animal and a sick animal were used as positive and negative controls respectively. d: a representative of the readings where a distinct peak corresponding to
hemoglobin beta ½ chain is marked, the comparison of the relative size of the peaks at different time points showed a correlation of the peak with implant integration. [Color ﬁgure
can be seen in the online version of this article, available at http://wileyonlinelibrary.com/bit]
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been previously shown to support human respiratory cell
proliferation. However in the view of the histological results,
in vivo growth of epithelium was still slow (limited to the
close proximity of the anastomosis sites). Epithelialization is
generally a long process, basically due to the mode of growth
of epithelium (Fong et al., 2010) and can only be overcome
by surface treatments with growth factor gradients to a
certain extent, as the boundary conditions cannot be
changed. However, surface coatings can further improve the
outcome. Previously in canine specimens the replacement of
epithelium was observed on a polycaprolactone (PCL) based
lumen coating of a collagen-based scaffold, but only after
18 months following the surgery (Sato et al., 2010). The
authors state that there was a distinct improvement in
epithelialization in the presence of the ﬁlm coating. In this
model, no prior autologous cell seeding was done. When
decellularized tracheal scaffolds were used, Go et al. (2010)
reported a distinct improvement in the case where
autologous cells were seeded. Initial attachment of the cells
becomes important, which can be very limited depending on
the surface properties of the implant.
To further improve the implant design, we coated the
lumen of the implants with collagen/alginate polyelectrolyte
multilayers cross-linked with genipin. This cross-linking
step was necessary to stabilize the ﬁlm in physiological
conditions (pH 7.4). The cross-linking was effective between
collagen chains. Genipin acts on collagen molecules with
primary amine groups and has the ability to form both intra
and intermolecular cross-links (Hwang et al., 2011).
However, we demonstrate that, alginate molecules from
Figure 5. Stability of the ﬁlm layer. The presence of ﬁlm layer was monitored (a–c) after 2 weeks, (d–f) after 4 weeks of implantation. The ﬁlm layer was in place but effects of
degradation was apparent, with occasional cracks and an increase in the surface roughness. Confocal images of the ﬁlm layer acquired at (g) time 0 and (h) after 4 weeks of in vivo
implantation. The ﬁlm layer was mostly intact, but the formation of further pores on the surface was visible (magniﬁcation 20). [Color ﬁgure can be seen in the online version of this
article, available at http://wileyonlinelibrary.com/bit]
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the cross-linked ﬁlm were maintained in physiological
conditions (Fig. S1). The exact mechanism of cross-linking
is not fully described, even though a mechanism based on
nitrogen-iridoid formation between C3 of genipin and the
primary amines of lysine, hydroxylysine and arginine
(Sundararaghavan et al., 2008) could be considered.
When these layer were built at high bilayer numbers (24),
a thick layer of ﬁlm on top of the porous PLLA/titanium
hybrid can be obtained (Fig. 6a,b). When the titanium
samples are dipped into the polyelectrolyte solutions, the
solutions cannot ﬂow into the pore areas and they form thin
ﬁlms even in the absence of PLLA, but these ﬁlms have
wrinkled surface features compared to the smooth surface
obtained in the case of PLLA/titanium. The thickness of this
ﬁlm layer determined by AFM was around 400 nm and the
components of the ﬁlm layer had a nanoﬁbrillar structure
which is known to improve the cell attachment due to its
similarity to basement membrane. This structure had a
surface roughness of 20 nm which is also appropriate for
epithelial cell culture (Fig. 6c,d).
Human respiratory epithelial cells attached and prolifer-
ated on these structures, with near conﬂuent layers obtained
by 10 days (Fig. 7a–e). Cells proliferated faster on these
structure compared to standard epithelial cell culture on
Transwell inserts and also the cell numbers were higher
compared to our previous results with PLLA ﬁlms (Vrana
et al., 2011). Transwell inserts were selected as control since
they are widely used for in vitro differentiation of epithelial
cells to ciliated epithelium by air–liquid interface culture
method, which is crucial for respiratory epithelium.
Moreover, in long term culture periods which are necessary
for differentiation, long-term viability of epithelial cells
was higher on collagen/alginate multilayers compared to
Transwell. Cells stayed on the implant surface even after
19 days of culture (Fig. 7d), whereas in the case of Transwell
and PLLA ﬁlms, cell numbers saw a decrease after 13 days.
To check the rate of migration, epithelial cells were observed
with time lapse microscopy and their migration rates were
calculated. In general cells migrated slower on collagen type
IV than onmultilayer counterparts (P< 0.05), whereas pure
Figure 6. Development of collagen/alginate multilayers on the implant lumen. a: A Thin layer of the collagen/alginate ﬁlm covers the surface of the implant over the titanium
beads and microporous PLLA body after 24 bilayers were deposited (b) which showed a strong attachment to the implant body. c: Films have on average a thickness around 400 nm
as determined by scratch tests (d) and they depicted a highly nanoﬁbrillar structure. [Color ﬁgure can be seen in the online version of this article, available at http://
wileyonlinelibrary.com/bit]
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collagen type I coating was a better surface for migration.
However, collagen type I by itself is not a good substrate for
respiratory epithelium proliferation, thus by using the LbL
technology a surface that behaves better than pure collagen
can be created. An additional coating of a collagen/alginate
multilayer would help the epithelialization of implants,
however with an average migration rate of 45.6mm/h, a 2 cm
defect can only be covered in about 10 days, if the movement
is unidirectional from the both anastomosis sites.
Thus our next step was to seed the epithelial cells to an
implant that has already been integrated with the body (after
3 weeks of implantation). This can be done endoscopically
with the modiﬁcation of already available endoscopical
intervention equipment. A possible option would be a
tubing system that will provide the airﬂow together with
a cartridge facing the lumen of the surface that needs to
be epithelialized ﬁlled with freshly isolated autologous
epithelium in autologous serum. This might provide an
‘‘on-site’’ method for the epithelialization of the implant.
In such a method, the epithelium would not need to
deal with the initial inﬂammation and it can grow on an
integrated structure thus the delay in vascularization
can be eliminated. As a proof of concept, Calcein-AM
labeled respiratory epithelial cells have been seeded on
implants just after explantation. These implants were
previously remodeled for 3 weeks between the infrahyoid
muscles and the trachea. The epithelial cells have attached
and spread on these surfaces in an hour (Fig. 8), which
indicates that in situ epithelialization is an achievable goal
in a clinical setting.
Figure 7. Human respiratory epithelial cell growth and migration on collagen/alginate coated implants. Collagen/alginate multilayers provided a better surface for cell
growth than Transwell. Cell numbers were signiﬁcantly higher than our previous system with PLLA ﬁlms too. a: Phase-contrast micrographs of conﬂuent respiratory epithelium
cells. b–d: DAPI/ZO-1 staining of the cells on the implants after days 7, 13, and 19 (magniﬁcation 10). e: Epithelial cell proliferation curve on collagen/alginate multilayers versus
Transwell and PLLA systems. Cell numbers were signiﬁcantly higher on collagen/alginate multilayers at days 3, 6, and 13. f: Macroscopic view of the coated cell seeded implant.
g: Rate of migration (mm/h) of respiratory epithelial cells on three substrates: collagen type I, collagen type IV, and collagen/alginate multilayers (n> 40). h,i: Representative images
of migration tests. [Color ﬁgure can be seen in the online version of this article, available at http://wileyonlinelibrary.com/bit]
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Conclusion
The hybrid PLLA/titanium tracheal implants can stop
the initial ingrowth of the ﬁbroblasts into the lumen. The
histology and blood characterization results showed that
the 3 weeks time-point is the optimal time delay for in situ
seeding of epithelial cells. Analysis of CRP and CGA levels
are viable methods to check the process of implant
integration. A further modiﬁcation of inner surface of the
implants with collagen/alginate multilayers resulted in a
400 nm thick ﬁbrillar ﬁlm which can support epithelial cell
growth and migration. As the next step, these implants will
be used for in situ epithelialization experiments.
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